Gain Therapeutics (NASDAQ:GANX) just reported results for the fourth quarter of 2023.
- Gain Therapeutics reported earnings per share of -29 cents. This was above the analyst estimate for EPS of -32 cents.
- The company did not report any revenue for the quarter.